Kolon TissueGene (950160) is continuing its upward trend for the sixth consecutive trading day. Market attention is focused on whether the stock can successfully "reclaim the 30,000-won level" on the 18th, the first trading day after the holiday.

◆ Six Consecutive Trading Days of Gains... Stock Touches 30,000 Won Intraday on the 14th

On the 14th, Kolon TissueGene closed at 28,550 won, up 2,950 won (11.52%) from the previous trading day. Opening the session at 26,800 won, the stock price surged to as high as 31,850 won intraday, touching the 30,000-won level once again.

Kolon TissueGene extended its upward streak for six consecutive trading days from the 7th through the 14th, when it even recorded a double-digit gain. Amid the continued rally, whether the stock can sustain its upward momentum after the holiday has emerged as a point of interest.

◆ Key Factor Is 'Settling Above the 30,000-Won Level'... Expanded Volatility Also a Variable

The key factor is whether the stock can settle above the 30,000-won level. Although it surpassed 30,000 won intraday on the 14th, the closing price formed in the 28,000-won range. Accordingly, it remains to be seen whether the stock will recover the 30,000-won level once again in the session on the 18th, and furthermore, whether it can establish a foothold at that price level. The possibility of expanded volatility resulting from the short-term consecutive gains is also something to watch.

◆ External Variables During the Holiday... Focus on the New York Stock Market and Inflation Indicators

External variables that emerge while the domestic market is closed for the holiday could also affect the stock price on the 18th. As the U.S. stock market has recently been moving in response to inflation indicators, attention is on how the direction of the New York stock market and changes in global investor sentiment during the holiday will influence the domestic market once it reopens.

In the United States, following the recent release of the July Consumer Price Index (CPI), the Producer Price Index (PPI) has also been announced, keeping market attention on inflation and monetary policy. Notably, both the CPI and PPI provided signals of easing inflation.

Attention is focused on whether Kolon TissueGene, which entered the holiday on a six-day winning streak, will maintain its momentum on the 18th and climb back above the 30,000-won level, or whether it will take a breather following its sharp short-term surge.

[This article was written for informational purposes only and does not constitute investment solicitation or a buy/sell recommendation for any specific stock. The final judgment and responsibility regarding investments rest with the investor.]